NASDAQ:ARWR

Arrowhead Research Stock News

etoro logo Buy ARWR
*Your capital is at risk
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
Seven nanotech stocks to buy have the potential to reward investors as innovation in the sector accelerates. The post 7 Nanotech Stocks To Buy With Huge Returns in Store appeared first on InvestorPlac
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead completes collaboration and license agreement with Takeda Pharmaceutical Company Limited
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q4 2020 Results - Earnings Call Transcript

Recap: Arrowhead Pharmaceuticals Q4 Earnings

05:21pm, Monday, 23'rd Nov 2020
Shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR) decreased 2.49% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 536.36% over the past ye
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead announced financial results for its fiscal year ended September 30, 2020
Aro Biotherapeutics today announced the appointments of Christopher K. Mirabelli, Ph.D., to its Board of Directors and Masad J. Damha, Ph.D., to its S
Arrowhead has 3 RNAi drugs in Phase 2 trials. Other companies have proven RNA-based commercial therapies.
Eli Lilly offers positive data for Jardiance in treating cardiovascular issues. Can-Fite moves forward with Piclidenoson for COVID-19.
The following slide deck was published by Arrowhead Pharmaceuticals, Inc. in conjunction with this event..
The following slide deck was published by Arrowhead Pharmaceuticals, Inc. in conjunction with this event..
The following slide deck was published by Arrowhead Pharmaceuticals, Inc. in conjunction with this event..
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Arrowhead Pharmaceuticals to present at August 2020 conferences
Arrowhead dosed the first patient in a clinical trial of RNAi based ARO-HIF2 for treatment of renal cell carcinoma
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE